Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
External validation of 18 F-FDG PET-based radiomic models on identification of residual oesophageal cancer after neoadjuvant chemoradiotherapy.
Valkema MJ, Beukinga RJ, Chatterjee A, Woodruff HC, van Klaveren D, Noordzij W, Valkema R, Bennink RJ, Roef MJ, Schreurs W, Doukas M, Lagarde SM, Wijnhoven BPL, Lambin P, Plukker JTM, van Lanschot JJB. Valkema MJ, et al. Among authors: doukas m. Nucl Med Commun. 2023 Aug 1;44(8):709-718. doi: 10.1097/MNM.0000000000001707. Epub 2023 May 3. Nucl Med Commun. 2023. PMID: 37132272 Free PMC article.
Residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer: locations undetected by endoscopic biopsies in the preSANO trial.
van der Wilk BJ, Eyck BM, Doukas M, Spaander MCW, Schoon EJ, Krishnadath KK, Oostenbrug LE, Lagarde SM, Wijnhoven BPL, Looijenga LHJ, Biermann K, van Lanschot JJB. van der Wilk BJ, et al. Among authors: doukas m. Br J Surg. 2020 Dec;107(13):1791-1800. doi: 10.1002/bjs.11760. Epub 2020 Aug 5. Br J Surg. 2020. PMID: 32757307 Free PMC article. Clinical Trial.
Surveillance of Clinically Complete Responders Using Serial 18F-FDG PET/CT Scans in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy.
Valkema MJ, van der Wilk BJ, Eyck BM, Wijnhoven BPL, Spaander MCW, Doukas M, Lagarde SM, Schreurs WMJ, Roef MJ, van Lanschot JJB, Valkema R. Valkema MJ, et al. Among authors: doukas m. J Nucl Med. 2021 Apr;62(4):486-492. doi: 10.2967/jnumed.120.247981. Epub 2020 Sep 4. J Nucl Med. 2021. PMID: 32887759 Free PMC article.
Updated protocol of the SANO trial: a stepped-wedge cluster randomised trial comparing surgery with active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancer.
Eyck BM, van der Wilk BJ, Noordman BJ, Wijnhoven BPL, Lagarde SM, Hartgrink HH, Coene PPLO, Dekker JWT, Doukas M, van der Gaast A, Heisterkamp J, Kouwenhoven EA, Nieuwenhuijzen GAP, Pierie JEN, Rosman C, van Sandick JW, van der Sangen MJC, Sosef MN, van der Zaag ES, Spaander MCW, Valkema R, Lingsma HF, Steyerberg EW, van Lanschot JJB; SANO-study group. Eyck BM, et al. Among authors: doukas m. Trials. 2021 May 17;22(1):345. doi: 10.1186/s13063-021-05274-w. Trials. 2021. PMID: 34001287 Free PMC article.
Shrinkage versus fragmentation response in neoadjuvantly treated oesophageal adenocarcinoma: significant prognostic relevance.
Graham Martinez C, Kus Öztürk S, Al-Kaabi A, Valkema MJ, Bokhorst JM, Rosman C, Rütten H, Wauters CAP, Doukas M, van Lanschot JJ, Siersema PD, Nagtegaal ID, van der Post RS. Graham Martinez C, et al. Among authors: doukas m. Histopathology. 2022 May;80(6):982-994. doi: 10.1111/his.14644. Epub 2022 Apr 6. Histopathology. 2022. PMID: 35352847 Free PMC article.
Detection of circulating tumour DNA after neoadjuvant chemoradiotherapy in patients with locally advanced oesophageal cancer.
Eyck BM, Jansen MP, Noordman BJ, Atmodimedjo PN, van der Wilk BJ, Martens JW, Helmijr JA, Beaufort CM, Mostert B, Doukas M, Wijnhoven BP, Lagarde SM, van Lanschot JJB, Dinjens WN. Eyck BM, et al. Among authors: doukas m. J Pathol. 2023 Jan;259(1):35-45. doi: 10.1002/path.6016. Epub 2022 Oct 31. J Pathol. 2023. PMID: 36196486 Free PMC article.
The effectiveness of neoadjuvant chemoradiotherapy in oesophageal adenocarcinoma with presence of extracellular mucin, signet-ring cells, and/or poorly cohesive cells.
Valkema MJ, Vos AM, van der Post RS, Ooms AH, Oudijk L, Eyck BM, Lagarde SM, Wijnhoven BP, Klarenbeek BR, Rosman C, van Lanschot JJB, Doukas M. Valkema MJ, et al. Among authors: doukas m. J Pathol Clin Res. 2023 Jul;9(4):322-335. doi: 10.1002/cjp2.321. Epub 2023 Mar 27. J Pathol Clin Res. 2023. PMID: 36971406 Free PMC article.
Active surveillance of oesophageal cancer after response to neoadjuvant chemoradiotherapy: dysphagia is uncommon.
Valkema MJ, Spaander MCW, Boonstra JJ, van Dieren JM, Hazen WL, Erkelens GW, Holster IL, van der Linden A, van der Linde K, Oostenbrug LE, Quispel R, Schoon EJ, Siersema PD, Doukas M, Eyck BM, van der Wilk BJ, van der Sluis PC, Wijnhoven BPL, Lagarde SM, van Lanschot JJB. Valkema MJ, et al. Among authors: doukas m. Br J Surg. 2023 Sep 6;110(10):1381-1386. doi: 10.1093/bjs/znad211. Br J Surg. 2023. PMID: 37418342 Free PMC article.
18 F-FDG PET/MRI for restaging esophageal cancer after neoadjuvant chemoradiotherapy.
Valkema MJ, de Lussanet de la Sablonière QG, Valkema R, Thomeer MGJ, Dwarkasing RS, Harteveld AA, Doukas M, Mostert B, van der Zijden CJ, van der Sluis PC, Lagarde SM, Wijnhoven BPL, Verburg FA, van Lanschot JJB. Valkema MJ, et al. Among authors: doukas m. Nucl Med Commun. 2024 Feb 1;45(2):128-138. doi: 10.1097/MNM.0000000000001793. Epub 2023 Nov 20. Nucl Med Commun. 2024. PMID: 37982560
204 results